Evidence map›Paper›PMID 37876500›Full record

ArticleDrug design, development and therapy2023

Yan Lan, Yu-Kun Zheng, Liu-Yi Wu, Zi-Jun Zhou, Ruo-Xin Guan, Heng Xu, Ji-Yuan Tu, Xin Gu, Rui Wang, Nan Jiang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Current pharmaceutical design · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yan Lan *Department of Pharmacy, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei, People's Republic of China.
Yu-Kun Zheng *College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Liu-Yi WuCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Zi-Jun ZhouCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Ruo-Xin GuanCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Heng XuCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Ji-Yuan TuCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Xin GuCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Rui WangCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Nan JiangCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Yuan WuDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Cheng-Ren ShuDepartment of Pharmacy, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei, People's Republic of China.
Zhong-Shi ZhouCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, People's Republic of China.
Hubei University of Chinese Medicine · CNHubei Polytechnic University · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Traditional Chinese medicine Methods: Potential targets for the analgesic effects of the main active components of PC alcohol extract were screened by network pharmacology and molecular docking. Three different inflammatory pain mouse models (acetic acid twisting, formalin foot swelling, and xylene ear swelling) were used to study the analgesic effects of PC. The expression of latent signaling pathways in L Results: Network pharmacology analysis shows that PC analgesic mechanism is related to the MAPK/ERK signaling pathway. The five main active components of PC have good docking ability with JNK and p38. PC alcohol extract significantly reduced the pain behavior and alleviated inflammatory reactions in three mouse models, inhibited the mRNA and protein phosphorylation levels of JNK, ERK, p38, and CREB in spinal cord tissues. Conclusion: PC alcohol extract can inhibit inflammation and alleviate pain, which is related to its inhibition of the MAPK/ERK signaling pathway in spinal cord. Thus, PC alcohol extract is a promising candidate for pain treatment.

Indexed as

Fallopia japonicaAnalgesicsAnimalsDisease Models, AnimalEthanolFormaldehydeInflammationMiceMolecular Docking SimulationPainPlant ExtractsRatsRats, Sprague-DawleySignal TransductionAnalgesicsEthanolFormaldehydePlant ExtractsanalgesicMAPK/ERKnetwork pharmacologyPolygonum cuspidatum

Identifiers

PMID37876500
PMCPMC10591627
OpenAlexW4387783316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.